These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19628316)

  • 1. Successful treatment with retinoids in patients with lupus nephritis.
    Kinoshita K; Kishimoto K; Shimazu H; Nozaki Y; Sugiyama M; Ikoma S; Funauchi M
    Am J Kidney Dis; 2010 Feb; 55(2):344-7. PubMed ID: 19628316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; Garrido Ed Ede R; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cyclosporin therapy of patients with systemic lupus erythematosus].
    Gergely P
    Orv Hetil; 1994 Nov; 135(47):2591-5. PubMed ID: 7824258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice.
    Nozaki Y; Yamagata T; Yoo BS; Sugiyama M; Ikoma S; Kinoshita K; Funauchi M; Kanamaru A
    Clin Exp Immunol; 2005 Jan; 139(1):74-83. PubMed ID: 15606616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
    Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids.
    Pepper R; Griffith M; Kirwan C; Levy J; Taube D; Pusey C; Lightstone L; Cairns T
    Nephrol Dial Transplant; 2009 Dec; 24(12):3717-23. PubMed ID: 19617257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
    Szeto CC; Kwan BC; Lai FM; Tam LS; Li EK; Chow KM; Gang W; Li PK
    Rheumatology (Oxford); 2008 Nov; 47(11):1678-81. PubMed ID: 18753192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of ultrahigh doses of corticosteroids in treating the most severe variants of lupus nephritis].
    Ianushkevich TN; Klepikov PV
    Ter Arkh; 1990; 62(6):50-3. PubMed ID: 2218927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus nephritis.
    Sauter M; Anders HJ
    Minerva Med; 2007 Dec; 98(6):749-58. PubMed ID: 18299686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: a prospective multi-centre observational study.
    Wang HY; Cui TG; Hou FF; Ni ZH; Chen XM; Lu FM; Xu FF; Yu XQ; Zhang FS; Zhao XZ; Zhao MH; Wang GB; Qian JQ; Cai GY; Zhu TY; Wang YH; Jiang ZP; Li YN; Mei CL; Zou WZ;
    Lupus; 2008 Jul; 17(7):638-44. PubMed ID: 18625636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intermittent intravenous administration of cyclophosphamide in patients with lupus nephritis].
    Morović-Vergles J; Galesić K; Dancuo I; Vergles D
    Acta Med Croatica; 2004; 58(1):13-7. PubMed ID: 15125388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.
    Yee CS; Gordon C; Dostal C; Petera P; Dadoniene J; Griffiths B; Rozman B; Isenberg DA; Sturfelt G; Nived O; Turney JH; Venalis A; Adu D; Smolen JS; Emery P
    Ann Rheum Dis; 2004 May; 63(5):525-9. PubMed ID: 15082482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lupus nephritis: retrospective analysis of the course of the disease].
    Djukanović L; Pavlović S; Blagojević R; Dimitrijević J; Stojsic T; Ratković M; Kazić K; Lezaić V; Naumović R
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():26-31. PubMed ID: 12583310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history and treatment of lupus nephritis.
    Austin HA; Balow JE
    Semin Nephrol; 1999 Jan; 19(1):2-11. PubMed ID: 9952276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimum therapeutic approaches for lupus nephritis: what therapy and for whom?
    Boumpas DT; Sidiropoulos P; Bertsias G
    Nat Clin Pract Rheumatol; 2005 Nov; 1(1):22-30. PubMed ID: 16932624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is combination rituximab with cyclophosphamide better than rituximab alone in the treatment of lupus nephritis?
    Li EK; Tam LS; Zhu TY; Li M; Kwok CL; Li TK; Leung YY; Wong KC; Szeto CC
    Rheumatology (Oxford); 2009 Aug; 48(8):892-8. PubMed ID: 19478041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-up.
    Moroni G; Gallelli B; Quaglini S; Banfi G; Rivolta E; Messa P; Ponticelli C
    Nephrol Dial Transplant; 2006 Jun; 21(6):1541-8. PubMed ID: 16455674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.